Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of CHOPi012-A iPSC line from a patient with visceral myopathy-related chronic intestinal pseudo-obstruction.

Stem cell research - 1 Sept 2023

Hashmi Sohaib K, Schneider Sabine, Gagne Alyssa L, Maguire Jean Ann, Gadue Paul, Heuckeroth Robert O, French Deborah L

Abstract excerpt

Visceral myopathies are debilitating conditions characterized by dysfunction of smooth muscle in visceral organs (bowel, bladder, and uterus). Individuals affected by visceral myopathy experience feeding difficulties, growth failure, life-threatening abdominal distension, and may depend on intravenous nutrition for survival. Unfortunately, our limited understanding of the pathophysiology of visceral myopathies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actins
Share to Induced Pluripotent Stem Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intestinal Pseudo-Obstruction

Share to Intestines

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 37572398
DOI: 10.1016/j.scr.2023.103176
PMCID: PMC11299795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of CHOPi012-A iPSC line from a patient with visceral myopathy-related chronic intestinal pseudo-obstruction.PMID 37572398Read ↗

Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.Semantic proximity Read ↗

Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton.Semantic proximity Read ↗

Expanding the genotypic spectrum of ACTG2-related visceral myopathy.Semantic proximity Read ↗

The Diverse Phenotype of Intestinal Dysmotility Secondary to ACTG2-related Disorders.Semantic proximity Read ↗

Pseudo-obstruction-inducing ACTG2R257C alters actin organization and function.Semantic proximity Read ↗

Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.Semantic proximity Read ↗

[ACTG2 associated visceral myopathy with intestinal pseudoobstruction].Semantic proximity Read ↗

Multi-disciplinary Insights from the First European Forum on Visceral Myopathy 2022 Meeting.Semantic proximity Read ↗

Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.Semantic proximity Read ↗

Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.Semantic proximity Read ↗

Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-ObstructionSemantic proximity Read ↗

Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.